NeoForm Annuloplasty Ring

K190506 · Genesee Biomedical, Inc. · KRH · Apr 18, 2019 · Cardiovascular

Device Facts

• Record ID: K190506
• Device Name: NeoForm Annuloplasty Ring
• Applicant: Genesee Biomedical, Inc.
• Product Code: KRH · Cardiovascular
• Decision Date: Apr 18, 2019
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.3800
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The NeoForm™ Annuloplasty Ring is indicated for the correction of mitral valvular insufficiency where the lesions are not so severe as to require total valve replacement.

Device Story

NeoForm™ Annuloplasty Ring is a rigid implantable device used during mitral valve repair surgery to reduce and stabilize the valve annulus. The device consists of a titanium alloy inner core, a silicone cover, and a polyester fabric sewing cuff. It is available in four sizes (26-32 mm). During surgery, the physician implants the ring to provide structural support and restrict pathological expansion of the mitral annulus. By restoring the geometry of the annulus, the device helps improve valve function and reduces insufficiency, potentially avoiding the need for total valve replacement.

Clinical Evidence

No clinical data. Substantial equivalence supported by non-clinical bench testing, including biocompatibility, sterilization validation, computational finite element analysis (FEA), tensile strength testing, suture pull-out testing, MRI compatibility, packaging, and shelf-life studies.

Technological Characteristics

Rigid annuloplasty ring; titanium alloy inner core; silicone cover; polyester fabric sewing cuff; polyester suture markers. Available in 26, 28, 30, and 32 mm sizes. Mechanical support principle. Non-software device.

Indications for Use

Indicated for patients with mitral valvular insufficiency requiring surgical repair, excluding cases severe enough to necessitate total valve replacement.

Regulatory Classification

Identification

An annuloplasty ring is a rigid or flexible ring implanted around the mitral or tricuspid heart valve for reconstructive treatment of valvular insufficiency.

Special Controls

*Classification.* Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Annuloplasty Rings 510(k) Submissions.”

Predicate Devices

• GeoForm™ Annuloplasty Ring, Model 4200 (K032250)

Reference Devices

• ATS Simulus™ Semi-Rigid Annuloplasty Ring, Model 800SR (K072655)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the FDA logo is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

April 18, 2019

Genesee BioMedical, Inc Mr. Woodrow Mathison President and CEO 700 W Mississippi Ave, Unit D5 Denver, Colorado 80223-4509

Re: K190506

Trade/Device Name: NeoForm™ Annuloplasty Ring Model 4200 Regulation Number: 21 CFR 870.3800 Regulation Name: Annuloplasty ring Regulatory Class: Class II Product Code: KRH Dated: February 28, 2019 Received: March 1, 2019

Dear Mr. Mathison:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

{1}------------------------------------------------

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## 510(k) Summary NeoForm™ Annuloplasty Ring

| Applicant | Genesee BioMedical, Inc.<br>700 W Mississippi Ave. Unit D5<br>Denver, Colorado 80223-4509 |
|-------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person | Woodrow G. Mathison, President and CEO<br>[e-mail]<br>Phone: [phone] Fax: [phone] |
| Date Prepared | April 15, 2019 |
| Trade Name | NeoForm™ Annuloplasty Ring Model 4200 |
| Common or Usual Name | Annuloplasty Ring |
| Classification | Class II Special Controls<br>Regulation Number: 21 CFR 870.3800 |
| Product Code | KRH |
| Review Panel | Cardiovascular |
| Predicate Device | The subject device is substantially equivalent to the GeoForm™<br>Annuloplasty Ring, Model 4200 (K032250). |
| Reference Device | ATS Simulus™ Semi-Rigid Annuloplasty Ring, Model 800SR<br>(K072655). |
| Device Description | The NeoForm™ Annuloplasty Ring, Model 4200 is a rigid<br>implantable annuloplasty ring designed to reduce and stabilize<br>the valve annulus in patients undergoing mitral repair.<br><br>The inner core of the ring is made of a titanium alloy. Silicone<br>covers the inner core and a sewing cuff made of polyester fabric<br>encompasses the ring. Three points of the ring are marked with<br>polyester suture to aid in suture placement for implantation.<br><br>The ring is available in four sizes: 26 mm; 28 mm; 30 mm; and<br>32 mm. |
| Indications for Use: | The NeoForm™ Annuloplasty Ring is indicated for the<br>correction of mitral valvular insufficiency where the lesions are<br>not so severe as to require total valve replacement. |
| Principle and Mechanism<br>of Operation | The NeoForm™ Annuloplasty Ring provides support for the<br>mitral annulus and restricts expansion of the annulus. |
| Functional and Safety<br>Testing | To verify that device design meets functional and performance<br>requirements, representative samples of the devices underwent<br>testing in accordance with applicable standards and guidance.<br>These data demonstrate the device is equivalent to the predicate<br>and/or reference device. |
| Comparative Technology<br>Characteristics | A comparison of the characteristics of the proposed device and<br>the predicate and/or reference device show the NeoForm™<br>Annuloplasty Ring to have the same technological<br>characteristics as the predicate device that has received 510(k)<br>clearance. |
| | Equivalence is based upon intended use, indications for use,<br>principles of operation and fundamental technology. Both<br>devices are intended for use in surgical repair of mitral heart<br>valves. |
| | The subject and predicate device have similar or identical<br>materials of composition, size range, sizing accessories and site<br>of application in the body. |
| | Changes between the device and predicate include minor<br>modifications to the structure, the sterilization method, and<br>packaging. |
| Non-Clinical Tests<br>Submitted | Testing was performed to support substantial equivalence,<br>including: |
| | Biocompatibility<br>Sterilization<br>Computational Finite Element Analysis (FEA)<br>Tensile strength of ring materials<br>Suture pull-out testing<br>MRI Compatibility<br>Packaging<br>Shelf-life |
| Conclusion | Genesee BioMedical, Inc. considers the NeoForm™<br>Annuloplasty Ring to be equivalent to the predicate device. This<br>conclusion is based upon the fact that the devices have an<br>equivalent intended use, and there are no differences that raise<br>different questions of safety and effectiveness. |

{3}------------------------------------------------

{4}------------------------------------------------

## Please wait...

If this message is not eventually replaced by the proper contents of the document, your PDF viewer may not be able to display this type of document.

You can upgrade to the latest version of Adobe Reader for Windows®, Mac, or Linux® by visiting http://www.adobe.com/go/reader_download.

For more assistance with Adobe Reader visit http://www.adobe.com/go/acrreader.

Windows is either a registered trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc., registered in the United States and other countries. Linux is the registered trademark of Linus Torvalds in the U.S. and other countries.